Dupilumab: short‐term effectiveness and security in real clinical practice – A retrospective multicentric study
- 10 June 2018
- journal article
- letter
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 33 (1) , E21-E22
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Dupilumab treatment in moderate-to-severe atopic dermatitis: A systematic review and meta-analysisJournal of Dermatological Science, 2018
- Dupilumab para el tratamiento de la dermatitis atópicaActas Dermo-Sifiliograficas, 2018
- Unravelling the complex genetic background of atopic dermatitis: from genetic association results towards novel therapeutic strategiesArchives of Dermatological Research, 2015
- Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approachesJournal of Allergy and Clinical Immunology, 2014
- TNF-α and Th2 Cytokines Induce Atopic Dermatitis–Like Features on Epidermal Differentiation Proteins and Stratum Corneum Lipids in Human Skin EquivalentsJournal of Investigative Dermatology, 2014
- Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitisJournal of Allergy and Clinical Immunology, 2012
- ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitisJournal of the European Academy of Dermatology and Venereology, 2010
- Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6Clinical Immunology, 2008